Sanofi India Ltd vs Wanbury Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Sanofi India Ltd is ₹ 3420 as of 04 May 11:02 . The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 7 quarters. This represents a CAGR of -100.00% The p/e ratio of Wanbury Ltd changed from 3.4 to 25.2 over 4 quarters. This represents a CAGR of 641.18% The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The market cap of Wanbury Ltd changed from ₹ 207.5 crore to ₹ 768.96 crore over 5 quarters. This represents a CAGR of 185.17% The revenue of Sanofi India Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Wanbury Ltd for the Jun '25 is ₹ 163.53 crore as compare to the Mar '25 revenue of ₹ 173.84 crore. This represent the decline of -5.93% The ebitda of Sanofi India Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Wanbury Ltd for the Jun '25 is ₹ 24.79 crore as compare to the Mar '25 ebitda of ₹ 31.47 crore. This represent the decline of -21.23% The net profit of Sanofi India Ltd changed from ₹ 136.6 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of -100.00% The net profit of Wanbury Ltd changed from ₹ 1.04 crore to ₹ 13.49 crore over 5 quarters. This represents a CAGR of 676.93% The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% The dividend payout of Wanbury Ltd changed from 0 % to 0 % over 10 quarters. This represents a CAGR of 0.0% .

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
It has its own manufacturing facility at Goa.

About Wanbury Ltd

Wanbury Limited, formerly known Pearl Organics Limited was incorporated in August, 1988.
The Company attained its present name in September 2004.
The Company is engaged in the business of pharmaceutical and related activities, including research. The company has established its first plant in the year 1992 in Tarapur for manufacturing APIs.
In 1995, the Company acquired plant of Brij Chemicals Pvt Ltd at Patalganga.
In 1996, it entered into a strategic alliance with Wyckoff Chemicals to manufacture its API in US. In 2007-08, the merger of Doctors Organic Chemicals Limited (DOCL) with the Company became effective from 1st April, 2007.

FAQs for the comparison of Sanofi India Ltd and Wanbury Ltd

Which company has a larger market capitalization, Sanofi India Ltd or Wanbury Ltd?

Market cap of Sanofi India Ltd is 8,111 Cr while Market cap of Wanbury Ltd is 901 Cr

What are the key factors driving the stock performance of Sanofi India Ltd and Wanbury Ltd?

The stock performance of Sanofi India Ltd and Wanbury Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi India Ltd and Wanbury Ltd?

As of May 4, 2026, the Sanofi India Ltd stock price is INR ₹3522.25. On the other hand, Wanbury Ltd stock price is INR ₹257.9.

How do dividend payouts of Sanofi India Ltd and Wanbury Ltd compare?

To compare the dividend payouts of Sanofi India Ltd and Wanbury Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.